RABEN DAVID (Chief Medical Officer) sold 9.0% of their position (5.50K shares) of BICARA THERAPEUTICS INC. on the open market
Open‑market sale worth $125.8K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 4/28/2026ACC: 0001628280-26-028054
Officer· Chief Medical Officer
Since Mar 2026
-5.50K
Net shares
Net seller
$125.8K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
5.50K acquired · 11K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+5.50K
Price / share
$3.79
Trade value
$20.84K
% of position
9.9%
4/27/2026
55.29K→60.79K
Common Stock
Direct
Shares
−5.50K
Price / share
$22.88
Trade value
$125.83K
% of position
9.0%
4/27/2026
60.79K→55.29K
Total
Net shares
+0.00
Net value
-$104.99K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/27/2026 | M · Option Exercise | +5.50K | $3.79 | $20.84K | 9.9% | 55.29K | 60.79K |
| Common Stock Direct | 4/27/2026 | S · Sale | −5.50K | $22.88 | $125.83K | 9.0% | 60.79K | 55.29K |
| Total | +0.00 | -$104.99K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
5.50K shares
Shares
−5.50K
Strike price
3.7898
Held after
41.91K
Exercisable
—
4/27/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock5.50K shares | 4/27/2026 | M · Option Exercise | −5.50K | 3.7898 | — | 41.91K |